Step by Stepa HemeOncBuddy patient portal

Eribulin

Illustration: Eribulin

Say it: air-ih-BYOO-lin · Brand names: Halaven

Eribulin is a chemotherapy medicine that stops cancer cells from dividing.

What it is

Cells need tiny inner tubes to split into two new cells. Eribulin blocks these tubes from growing. The cancer cell cannot divide and dies.

Often used for

How you get it

Eribulin is given through a vein (IV) in a clinic. It takes about 2 to 5 minutes. It is usually given on day 1 and day 8 of a 3 week cycle. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

Questions to ask

Side effect guides

Sources

Quick answers

What is Eribulin?
Eribulin is a chemotherapy medicine that stops cancer cells from dividing. Brand names: Halaven.
What is Eribulin used for?
breast cancer that has spread; liposarcoma (a type of fat tissue cancer) that has spread.
How is Eribulin given?
Eribulin is given through a vein (IV) in a clinic. It takes about 2 to 5 minutes. It is usually given on day 1 and day 8 of a 3 week cycle. Your schedule may be different.
What are the common side effects of Eribulin?
Low white blood cell count. Feeling tired or weak. Hair loss. Numbness or tingling in the hands or feet. Upset stomach. Constipation.
When should I call my care team while taking Eribulin?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; Chills, a sore throat, a cough, or burning when you pee (signs of infection); A fast, slow, or uneven heartbeat, or feeling faint; Numbness or tingling that makes it hard to walk or use your hands; Throwing up or diarrhea so bad you cannot keep fluids down.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.